Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Schols

Showing results (21-30 of 134) with videos related to

Pageof 14
Sort By:
Virology|April 1, 1990
Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1D Schols, R Pauwels, J Desmyter, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|March 5, 2004
X4 HIV-1 induces neuroblastoma cell death by interference with CXCL12/CXCR4 interactionS Hatse, G Bridger, E de Clercq, et al.
Journal of Virology|October 6, 1997
RANTES and MCP-3 inhibit the replication of T-cell-tropic human immunodeficiency virus type 1 strains (SF-2, MN, and HE)D Schols, P Proost, J Van Damme, et al.
Biochemical and Biophysical Research Communications|July 31, 1991
1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2',3'-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytesJ Balzarini, C K Lee, D Schols, et al.
Biochemical and Biophysical Research Communications|July 15, 1991
Activity of acyclic nucleoside phosphonate analogues against human immunodeficiency virus in monocyte/macrophages and peripheral blood lymphocytesJ Balzarini, C F Perno, D Schols, et al.
Journal of Virology|April 29, 1998
T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor useD Schols, J A Esté, C Cabrera, et al.
Antiviral Research|August 1, 1997
Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4D Schols, J A Esté, G Henson, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Sulfated polysaccharides as potent inhibitors of HIV-induced syncytium formation: a new strategy towards AIDS chemotherapyM Baba, D Schols, R Pauwels, et al.
Journal of Virological Methods|November 1, 1991
Sensitive, reproducible and convenient fluorometric assay for the in vitro evaluation of anti-cytomegalovirus agentsJ Neyts, R Snoeck, D Schols, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1992
Activity of different antiviral drug combinations against human cytomegalovirus replication in vitroR Snoeck, G Andrei, D Schols, et al.
Pageof 14

Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
Virology|April 1, 1990
Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1D Schols, R Pauwels, J Desmyter, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|March 5, 2004
X4 HIV-1 induces neuroblastoma cell death by interference with CXCL12/CXCR4 interactionS Hatse, G Bridger, E de Clercq, et al.
Journal of Virology|October 6, 1997
RANTES and MCP-3 inhibit the replication of T-cell-tropic human immunodeficiency virus type 1 strains (SF-2, MN, and HE)D Schols, P Proost, J Van Damme, et al.
Biochemical and Biophysical Research Communications|July 31, 1991
1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2',3'-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytesJ Balzarini, C K Lee, D Schols, et al.
Biochemical and Biophysical Research Communications|July 15, 1991
Activity of acyclic nucleoside phosphonate analogues against human immunodeficiency virus in monocyte/macrophages and peripheral blood lymphocytesJ Balzarini, C F Perno, D Schols, et al.
Journal of Virology|April 29, 1998
T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor useD Schols, J A Esté, C Cabrera, et al.
Antiviral Research|August 1, 1997
Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4D Schols, J A Esté, G Henson, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Sulfated polysaccharides as potent inhibitors of HIV-induced syncytium formation: a new strategy towards AIDS chemotherapyM Baba, D Schols, R Pauwels, et al.
Journal of Virological Methods|November 1, 1991
Sensitive, reproducible and convenient fluorometric assay for the in vitro evaluation of anti-cytomegalovirus agentsJ Neyts, R Snoeck, D Schols, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1992
Activity of different antiviral drug combinations against human cytomegalovirus replication in vitroR Snoeck, G Andrei, D Schols, et al.
Pageof 14